- Home
- STVN vs UGI Comparison
STVN vs UGI Comparison
Compare STVN & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STVN
- UGI
- Stock Information
- Founded
- STVN 1949
- UGI 1940
- Country
- STVN Italy
- UGI United States
- Employees
- STVN N/A
- UGI N/A
- Industry
- STVN Containers/Packaging
- UGI Natural Gas Distribution
- Sector
- STVN Consumer Discretionary
- UGI Utilities
- Exchange
- STVN Nasdaq
- UGI Nasdaq
- Market Cap
- STVN 7.4B
- UGI 8.1B
- IPO Year
- STVN 2021
- UGI N/A
- Fundamental
- Price
- STVN $22.87
- UGI $38.98
- Analyst Decision
- STVN Buy
- UGI Buy
- Analyst Count
- STVN 4
- UGI 1
- Target Price
- STVN $25.88
- UGI $39.00
- AVG Volume (30 Days)
- STVN 360.6K
- UGI 2.3M
- Earning Date
- STVN 11-06-2025
- UGI 11-20-2025
- Dividend Yield
- STVN 0.27%
- UGI 3.84%
- EPS Growth
- STVN 19.61
- UGI 147.20
- EPS
- STVN 0.60
- UGI 3.09
- Revenue
- STVN $1,373,219,524.00
- UGI $7,287,000,000.00
- Revenue This Year
- STVN $8.33
- UGI $27.27
- Revenue Next Year
- STVN $10.12
- UGI $2.85
- P/E Ratio
- STVN $38.31
- UGI $12.64
- Revenue Growth
- STVN 6.97
- UGI 1.07
- 52 Week Low
- STVN $17.81
- UGI $26.73
- 52 Week High
- STVN $28.00
- UGI $39.27
- Technical
- Relative Strength Index (RSI)
- STVN 45.20
- UGI 86.66
- Support Level
- STVN $20.67
- UGI $34.39
- Resistance Level
- STVN $24.01
- UGI $39.27
- Average True Range (ATR)
- STVN 1.23
- UGI 0.89
- MACD
- STVN 0.06
- UGI 0.49
- Stochastic Oscillator
- STVN 45.08
- UGI 95.59
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.